Analyst Price Target is $152.77
▼ -11.85% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for PerkinElmer in the last 3 months. The average price target is $152.77, with a high forecast of $193.00 and a low forecast of $49.00. The average price target represents a -11.85% upside from the last price of $173.32.
Current Consensus is
The current consensus among 8 contributing investment analysts is to buy stock in PerkinElmer. This rating has held steady since October 2019, when it changed from a Hold consensus rating.
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.